Davis C. Woodworth

Davis C. Woodworth

Auto-generated profile, based on publicly available information

Davis C. Woodworth

Department of Neurology, University of California, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2022 in Brain Communications
Verified
Journal Article
Open access
PDF file
DWDavis C. Woodworth
Davis C. Woodworth
NSNasim Sheikh-Bahaei
Nasim Sheikh-Bahaei
KSKiana A. Scambray
Kiana A. Scambray
MPMichael J. Phelan
Michael J. Phelan
MPMari Perez-Rosendahl
Mari Perez-Rosendahl
FIFor The Alzheimer'S Disease Neuroimaging Initiative
For The Alzheimer'S Disease Neuroimaging Initiative
Brain atrophy is associated with degenerative neuropathologies and the clinical status of dementia. Whether dementia is associated with atrophy independent of neuropathologies is not known. In this study, we examined the pattern of atrophy associated with dementia while accounting for the most common dementia-related neuropathologies. We used data from National Alzheimer’s Coordinating Center (n = 129) and Alzheimer’s Disease Neuroimaging Initiative (n = 47) participants with suitable in vivo 3D-T1w MRI and autopsy data. We determined dementia status at the visit closest to MRI. We examined the following dichotomized neuropathological variables: Alzheimer’s disease neuropathology, hippocampal sclerosis, Lewy bodies, cerebral amyloid angiopathy and atherosclerosis. Voxel-based morphometry identified areas associated with dementia after accounting for neuropathologies. Identified regions of interest were further analysed. We used multiple linear regression models adjusted for neuropathologies and demographic variables. We also examined models with dementia and Clinical Dementia Rating sum of the boxes as the outcome and explored the potential mediating effect of medial temporal lobe structure volumes on the relationship between pathology and cognition. We found strong associations for dementia with volumes of the hippocampus, amygdala and parahippocampus (semi-partial correlations ≥ 0.28, P < 0.0001 for all regions in National Alzheimer’s Coordinating Center; semi-partial correlations ≥ 0.35, P ≤ 0.01 for hippocampus and parahippocampus in Alzheimer’s Disease Neuroimaging Initiative). Dementia status accounted for more unique variance in atrophy in these structures (∼8%) compared with neuropathological variables; the only exception was hippocampal sclerosis which accounted for more variance in hippocampal atrophy (10%). We also found that the volumes of the medial temporal lobe structures contributed towards explaining the variance in Clinical Dementia Rating sum of the boxes (ranging from 5% to 9%) independent of neuropathologies and partially mediated the association between Alzheimer’s disease neuropathology and cognition. Even after accounting for the most common neuropathologies, dementia still had among the strongest associations with atrophy of medial temporal lobe structures. This suggests that atrophy of the medial temporal lobe is most related to the clinical status of dementia rather than Alzheimer's disease or other neuropathologies, with the potential exception of hippocampal sclerosis.

5 May 2025 in Brain
Verified
Journal Article
Open access
DWDavis C Woodworth
Davis C Woodworth
JLJerry J Lou
Jerry J Lou
WYWilliam H Yong
William H Yong
EHELIZABETH HEAD
ELIZABETH HEAD
MCMaría M Corrada
María M Corrada
SSS Ahmad Sajjadi
S Ahmad Sajjadi
Hippocampal sclerosis of ageing (HS-A)—severe cell loss and gliosis in the hippocampal formation—is a neuropathologic change (NC) that affects up to 20% of elderly persons with dementia. The aetiology of HS-A is heterogeneous, but HS-A is strongly associated with limbic-predominant age-related TDP-43 encephalopathy NC (LATE-NC). Other NCs have also been implicated in relation to HS-A, but these associations have been inconsistent across previous studies. Also, because LATE-NC and HS-A are so strongly associated, it is important to adjust for LATE-NC when examining associations between other NCs and HS-A. The goal of this study was to examine associations of other common NCs with HS-A, both before and after adjusting for LATE-NC. We analysed the National Alzheimer’s Coordinating Center (NACC) neuropathology dataset and examined associations of Alzheimer’s disease NC (ADNC), Lewy bodies (LB) and cerebrovascular NCs, with HS-A, adjusting for LATE-NC in multiple ways. We used Bayesian multilevel logistic regression models with monotonic modelling for ordinal predictors and report the odds ratios (OR) or average OR across levels (aOR), along with 95% credibility intervals (CI) as well as expected frequencies of HS-A for selected models and predictor levels. Of n = 1933 autopsy participants included (average age at death of 83 years, 51.3% women), HS-A was present in 278 (14.4%). LATE-NC was strongly associated with HS-A (aOR = 3.7, 95% CI = 2.8, 5.0). While ADNC showed a modest association with HS-A in models where LATE-NC was not included as a predictor (aOR = 1.4, CI = 1.1, 1.8), this association was reduced when adjusting for LATE-NC (aOR = 1.11, CI = 0.9, 1.5); results were similar for the ADNC-related A/B/C scores and limbic LBs. However, several cerebrovascular NCs were similarly associated with HS-A both without adjusting for LATE-NC [atherosclerosis aOR = 1.4, arteriolosclerosis aOR = 1.6, white matter rarefaction (WMR) aOR = 1.4] and with adjusting for LATE-NC (atherosclerosis aOR = 1.4, arteriolosclerosis aOR = 1.5, WMR aOR = 1.3). In a combined model, LATE-NC was strongly associated with HS-A, but global cerebrovascular NCs, as well as APOE-ε4 (increased odds) and education (decreased odds), were also associated with HS-A. Predicted HS-A frequency for predictor levels of no LATE-NC or global cerebrovascular NCs was 1.5% (CI = 0.6%, 3.1%), while it was 94.5% (CI = 84%, 99.5%) for LATE-NC stage 3 and severe global cerebrovascular NC levels. LATE-NC is likely the most important cause of HS-A. While ADNC seems to be associated with HS-A through its association with LATE-NC, the association of cerebrovascular NCs with HS-A independent of LATE-NC underlines the importance of vascular factors in the aetiology of HS-A.

1 October 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
DWDavis C. Woodworth
Davis C. Woodworth
KNKatelynn M. Nguyen
Katelynn M. Nguyen
Lorena SordoLorena Sordo
Lorena Sordo
KSKiana A. Scambray
Kiana A. Scambray
EHELIZABETH HEAD
ELIZABETH HEAD
SSS. Ahmad Sajjadi
S. Ahmad Sajjadi
INTRODUCTION: Limbic‐predominant age‐related TAR DNA‐binding protein of 43 kDa encephalopathy neuropathologic change (LATE‐NC) staging criteria were updated in 2023. We evaluated this updated staging using National Alzheimer's Coordinating Center data.METHODS: We examined associations of LATE‐NC stages with cognition and other neuropathologic changes (NCs), and with cognition while accounting for other NCs, using multilevel regression models.RESULTS: Of 1352 participants, 502 (37%) had LATE‐NC (23% stage 1a, 6% stage 1b, 58% stage 2, 13% stage 3). LATE‐NC stages were associated with cognition, hippocampal sclerosis of aging (HS‐A), Alzheimer's disease NC (ADNC), Lewy bodies (LBs), and hippocampal atrophy. While stage 1b was associated with cognition and HS‐A consistent with other stages, it was not associated with ADNC or LBs. All LATE‐NC stages remained significantly associated with worse cognition when accounting for other NCs.DISCUSSION: The updated LATE‐NC staging criteria capture variations in early TDP‐43 pathology spread which are consequential for cognition and associations with other NCs.Highlights: We applied the updated limbic‐predominant age‐related TAR DNA‐binding protein of 43 kDa encephalopathy neuropathologic change (LATE‐NC) staging criteria to data from the National Alzheimer's Coordinating Center. LATE‐NC stage 1b was identified in 22% of participants with stage 1. In contrast to other LATE‐NC stages, stage 1b was not associated with Alzheimer's disease neuropathologic change (ADNC) or Lewy bodies. Stages 1a and 1b were significantly associated with dementia and memory impairment. Stages 1b+ were more strongly tied to dementia than all other neuropathologic changes except high likelihood ADNC.

6 July 2026 in The Journal Of Prevention of Alzheimer's Disease
Verified
Journal Article
Open access
EGElham Ghanbarian
Elham Ghanbarian
BKBabak Khorsand
Babak Khorsand
LZLukai Zheng
Lukai Zheng
DWDavis C. Woodworth
Davis C. Woodworth
Crystal M GloverCrystal M Glover
Crystal M Glover
AEAli Ezzati
Ali Ezzati
Hippocampal atrophy is a key marker of Alzheimer's disease (AD)- related neurodegeneration; however, hippocampal volume alone may not fully capture heterogeneity in cognitive decline. Left-right hippocampal asymmetry may provide complementary information, but its prognostic value for long-term cognitive decline, particularly in relation to AD pathology, remains unclear. To determine whether hippocampal total volume and left-right hippocampal asymmetry provide complementary and independent information in capturing cognitive decline and clinical progression, and to examine their relationship to AD pathology. Analysis of baseline MRI and longitudinal cognitive data over 10 years in four domains of memory, language, executive, and visuospatial function, using harmonized cognitive data from the Alzheimer's Disease Sequencing Project - Phenotype Harmonization Consortium (ADSP-PHC). Participants from ADNI 1, ADNI GO, ADNI 2, and ADNI 3 PARTICIPANTS: A total of 1,142 dementia-free participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) with available baseline structural MRI, cerebrospinal fluid (CSF) amyloid-β (Aβ42) and phosphorylated tau (p-tau-181), and longitudinal cognitive follow-up. Total hippocampal volume (left + right) and hemispheric asymmetry (absolute left-right volumetric difference) were modeled simultaneously. Linear mixed-effects models examined associations with baseline performance and longitudinal change across four cognitive domains. Cox proportional hazards models assessed risk of clinical progression to clinical dementia over up to 10 years of follow-up (median follow-up 4 years; median 5 visits per participant). All analyses adjusted for age, sex, education, APOE ε4 status, and CSF biomarkers, with stratification by amyloid status. The study cohort included 546 women (47.8%), with a mean age of 72.54 ± 6.98 years. Smaller total hippocampal volume was consistently associated with worse baseline performance and faster decline across all four cognitive domains, even after adjustment for amyloid and tau. In contrast, greater left-right hippocampal asymmetry was selectively associated with worse performance and faster decline in memory, independent of total hippocampal volume. In amyloid-stratified analyses, total hippocampal volume showed broad associations with cognitive performance across multiple domains in both amyloid-positive and amyloid-negative participants, whereas hippocampal left-right asymmetry demonstrated selective associations with memory performance, which were observed only among amyloid-negative individuals. With respect to clinical progression to dementia, smaller total hippocampal volume was associated with a higher risk of progression in the overall cohort and within both amyloid groups. In contrast, hippocampal asymmetry was associated with progression risk only among amyloid-negative individuals (hazard ratio per SD increase = 1.31, 95% CI: 1.03-1.65). Hippocampal total volume and asymmetry capture distinct aspects of neurodegeneration, with asymmetry providing additional prognostic information for memory decline and clinical progression in the absence of detectable amyloid pathology.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SDShubir Dutt
Shubir Dutt
DWDavis C. Woodworth
Davis C. Woodworth
SSS. Ahmad Sajjadi
S. Ahmad Sajjadi
CKClaudia H. Kawas
Claudia H. Kawas
MCMaria Corrada-Bravo
Maria Corrada-Bravo
DNDaniel A. Nation
Daniel A. Nation
Background: Cerebrovascular contributions to cognitive aging and Alzheimer’s disease (AD) risk represent a growing field in aging research. Studies in the young‐old have demonstrated the critical role of vascular dysregulation (i.e., altered cerebral blood flow) in relation to cognitive decline prior to the appearance of amyloid/tau biomarkers. However, cerebral perfusion has not been well‐studied in the oldest‐old (ages 90 and over), a rapidly growing population that may provide unique insight into resilience and protective factors against dementia in later life. We characterized amyloid and cerebral perfusion profiles of cognitively normal (CN) and cognitively impaired without dementia (CIND) oldest‐old individuals.Method: Participants were 97 dementia‐free older adults (70 CN and 27 CIND) from the 90+ Study who had available neuroimaging (T1‐MRI, ASL‐MRI, Florbetapir‐PET), demographic, and clinical data. We examined differences between CN and CIND in regional perfusion in areas associated with AD risk (medial temporal lobe, posterior cingulate, precuneus, frontal cortex, inferior parietal lobe) and in amyloid burden using linear regression models controlling for age, sex, education, APOE4 status, and vascular risk factors.Result: CN and CIND groups did not differ in the characteristics compared (Table 1). CIND participants had lower CBF in the posterior cingulate/precuneus than the CN group, but groups did not differ in posterior cingulate/precuneus amyloid SUVR (Figure 1). Additionally, CIND had lower CBF than CN in the inferior parietal lobe but higher CBF in the medial temporal lobe and orbitofrontal cortex (Figure 2).Conclusion: CIND individuals had lower regional perfusion in the posterior cingulate/precuneus, but groups did not differ in amyloidosis, highlighting the relationship between cerebrovascular function and cognitive status in the oldest‐old independent of amyloidosis. Our findings complement previously reported posterior cingulate/precuneus hypoperfusion in younger‐old individuals with cognitive impairment and AD. Interestingly, we observed greater medial temporal/frontal perfusion in CIND than CN, similar to previous studies demonstrating initial hyperperfusion preceding hypoperfusion across the CN‐CIND‐Dementia spectrum. This may represent a compensatory vascular mechanism supporting cognition in individuals at greater risk of developing dementia. Future studies will further characterize this cohort with longitudinal perfusion analyses, neuropsychological correlates, and relationships between perfusion and other indices of cerebrovascular dysfunction.

24 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
DWDavis C. Woodworth
Davis C. Woodworth
JLJanice X. Li
Janice X. Li
SFSina Faramarzi
Sina Faramarzi
DGDana E. Greenia
Dana E. Greenia
SBSyed A. Bukhari
Syed A. Bukhari
SSS. Ahmad Sajjadi
S. Ahmad Sajjadi
Background: Hippocampal sclerosis of aging (HS) is the neuropathological finding of neuronal death and gliosis in the hippocampus. HS is more prevalent, and associated with dementia, in the oldest‐old (those = 90 years), but cannot be diagnosed during life. HS is often unilateral and can be missed if only one brain hemisphere is assessed, which is standard neuropathological practice but may hamper the development of biomarkers for HS. Here we examined hippocampal volumes from antemortem MRI in relation to bilaterally‐assessed HS at autopsy, accounting for side, in oldest‐old participants from The 90+ Study.Method: We included participants with both autopsy and antemortem MRI data. All participants had neuropathological assessment of HS for both hemispheres. We performed hippocampal segmentation of antemortem 3D‐T1w MRIs using FreeSurfer, adjusting by intracranial volume. We compared total average (average of left and right), left, and right, hippocampal volumes between those with and those without HS. For HS participants we combined the hippocampal volumes from each hemisphere with HS into a single group and from each hemisphere without HS into a separate group, and compared these to the average hippocampal volumes from those without HS. We used Welch’s T‐tests for comparisons and report Cohen’s d effect sizes.Result: Participant characteristics (N = 89) are shown in Table‐1. All HS was unilateral (Right = 6, Left = 4). Average total hippocampal volume was not significantly different between those with and those without HS (d = 0.51, P = 0.11, Figure‐1a). However, right hippocampal volumes were significantly related to right‐sided HS with a large effect size (P = 0.002, d = 1.02) and left hippocampal volumes had a large effect size for left‐sided HS (P = 0.17, d = 0.90, Figure‐1c), whereas this was not the case when HS was on the opposite side (P>0.3, d<0.4, Figure‐1b,c). Combined HS participant hippocampal volumes for the side with HS (d = 0.98, P = 0.003), but not the side without HS (d = ‐0.14, P = 0.7), were different from volumes in participants without HS (Figure‐1d).Conclusion: Our results suggest HS is detectable by atrophy on antemortem MRI, but most strongly when using hippocampal volumes from the same side as HS. Researchers should consider assessing and documenting the presence of HS in both hemispheres to accelerate development of neuroimaging biomarkers for HS.